SAPA NE 2020-2021 Leadership Team

Acting President: Guiqing Liang, Ph.D. (Vertex Pharmaceuticals)

President-Elect: James Jianming Chao, Ph.D. (Sanofi)

Immediate Past President: Qiying Hu, Ph.D. (Oncorus)

Secretary General: Kehao Zhao, Ph.D. (Elpis Biopharmaceuticals) 

Executive Committee Members

 

  • Lin Lin, Ph.D. (Beth Israel Deaconess Medical Center and Harvard Medical School) 
  • Kejie Li, Ph.D. (Biogen)
  • Chao Zheng, Ph.D. (Harvard Medical School/Massachusetts General Hospital)
  • Dong Yang, Ph.D. (BMS)
  • Haishan Li, Ph.D. (Perkin Elmer)
  • Huijuan Li, Ph.D. (Moderna Therapeutics)
  • Jun Zhao (Merck)
  • Pei Ma, Ph.D. (Foundation)
  • Zhen Tong, Ph.D. (BMS)
  • Haiying Liu, Ph.D. (Johnson & Johnson)
  • Hongwei Howie Zhang, Ph.D. (MCPHS University)
  • Joyce Yin-Chieh Chen, MBA (Boston Institute of Biotechnology)
  • Mingde David Shan, Ph.D. (Eisai)
  • Tracy Yuanfan Zhang (Harvard Medical School/Boston Children's Hospital)
  • Xingfeng Bao, Ph.D. (Eisai)
  • Peng Sun, Ph.D., J.D. (Sarepta Therapeutics)
  • Yu Chen, MS MBA (WuXi AppTec)
  • Yudan Zhang, MS (EY)
  • ShiZhe Hui, MEng (iHisto)